Search results

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

ANSTO expert in molecular imaging contributed to international workshop.

Datasets from the Aerosol Sampling Program.

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

The Infrared microspectroscopy microscopes can record spectra from a range of different samples; from thin microtomed sections to polished blocks and embedded particles. This section highlights the types of samples that can be analysed using the IRM beamline

Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.

Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

X-ray fluorescence scanner is a powerful analytical tool for environmental studies.

Archive of ANSTO research publications, seminars and short talks.